Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Isenberg

Showing results (431-440 of 519) with videos related to

Pageof 52
Sort By:
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLEC Vitali, W Bencivelli, D A Isenberg, et al.
British Journal of Rheumatology|June 1, 1988
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogueD A Yardumian, D A Isenberg, M Rustin, et al.
Lupus|January 17, 2003
Disturbances in peripheral blood B cell subpopulations in autoimmune patientsK N Potter, C I Mockridge, A Rahman, et al.
Lupus|August 30, 2003
The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosusR L Bates, S J Payne, S L Drury, et al.
International Journal of Immunopharmacology|January 1, 1981
Cyclosporin A for the treatment of systemic lupus erythematosusD A Isenberg, M L Snaith, W J Morrow, et al.
Clinical and Experimental Immunology|June 17, 2005
Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patientsM R J Green, A S M Kennell, M J Larche, et al.
Annals of the Rheumatic Diseases|February 1, 1992
Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosusA J MacGregor, V B Dhillon, A Binder, et al.
The New England Journal of Medicine|September 25, 1980
Cyclosporin relieves arthralgia, causes angioedemaD A Isenberg, M L Snaith, A A Al-Khader, et al.
Immunology|March 1, 1993
Primary sequence and location of the idiotopes of V-88, a DNA-binding monoclonal autoantibody, determined by idiotope scanning with synthetic peptides on pinsN A Staines, F J Ward, A N Denbury, et al.
The Journal of Rheumatology|July 1, 1992
Asialylated IgG in the serum and synovial fluid of patients with rheumatoid arthritisR Casburn-Budd, P Youinou, H Hager, et al.
Pageof 52

Showing results (431-440 of 519) with videos related to

Sort By:
Pageof 52
Clinical and Experimental Rheumatology|September 1, 1992
Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLEC Vitali, W Bencivelli, D A Isenberg, et al.
British Journal of Rheumatology|June 1, 1988
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogueD A Yardumian, D A Isenberg, M Rustin, et al.
Lupus|January 17, 2003
Disturbances in peripheral blood B cell subpopulations in autoimmune patientsK N Potter, C I Mockridge, A Rahman, et al.
Lupus|August 30, 2003
The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosusR L Bates, S J Payne, S L Drury, et al.
International Journal of Immunopharmacology|January 1, 1981
Cyclosporin A for the treatment of systemic lupus erythematosusD A Isenberg, M L Snaith, W J Morrow, et al.
Clinical and Experimental Immunology|June 17, 2005
Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patientsM R J Green, A S M Kennell, M J Larche, et al.
Annals of the Rheumatic Diseases|February 1, 1992
Fasting lipids and anticardiolipin antibodies as risk factors for vascular disease in systemic lupus erythematosusA J MacGregor, V B Dhillon, A Binder, et al.
The New England Journal of Medicine|September 25, 1980
Cyclosporin relieves arthralgia, causes angioedemaD A Isenberg, M L Snaith, A A Al-Khader, et al.
Immunology|March 1, 1993
Primary sequence and location of the idiotopes of V-88, a DNA-binding monoclonal autoantibody, determined by idiotope scanning with synthetic peptides on pinsN A Staines, F J Ward, A N Denbury, et al.
The Journal of Rheumatology|July 1, 1992
Asialylated IgG in the serum and synovial fluid of patients with rheumatoid arthritisR Casburn-Budd, P Youinou, H Hager, et al.
Pageof 52